Small-scale systems for in vivo drug delivery

By D. Laván, Terry McGuire, Robert Langer. Nature Biotechnology, 2003

1,285 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Cellular and Molecular Neuroscience

View Paper: https://www.semanticscholar.org/paper/90252dd39f86a8b7517d9892df67c353dbfaea1a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

In Cellular and Molecular Neuroscience

Citations in the corpus

Three-dimensional thin-film Li-ion microbatteries for autonomous MEMS (2005, background): “5-mm-thick substrate will provide up to 1 mWh, enough for many projected autonomous MEMS uses, for example in smart drug delivery [19] and other miniaturized”
Drug delivery and nanoparticles: Applications and hazards (2008, background): “The whole system leads to a special function related to treating, preventing or diagnosing diseases sometimes called smart-drugs or theragnostics (LaVan et al 2003).”
Nanoparticle‐induced platelet aggregation and vascular thrombosis (2005, methodology): “For this study, we selected engineered carbon nanoparticles (C60CS, SWNT and MWNT) that are frequently used in drug discovery and delivery (LaVan et al., 2002; 2003), and MCN and SRM1648, which are a part of airborne PM present in the industrial environment.”
The Smart Drug Delivery System and Its Clinical Potential (2016, background): “A great number of smart DDSs have been developed over the last decades [8, 182, 183].”
Non-commercial Research and Educational Use including without Limitation Use in Instruction at Your Institution, Sending It to Specific Colleagues That You Know, and Providing a Copy to Your Institution's Administrator. All Other Uses, Reproduction and Distribution, including without Limitation Comm (2005, neutral): “NMR spectra of molecules partially oriented in an anisotropic liquid-crystalline environment provide detailed information about interactions that cannot be observed in the isotropic phase.”
Nanocarriers as an emerging platform for cancer therapy. (2007, background): “These nanocarriers have been explored for a variety of applications such as drug delivery, imaging, photothermal ablation of tumours, radiation sensitizers, detection of apoptosis, and sentinel lymph-node mappin”
A Comprehensive Survey of Recent Advancements in Molecular Communication (2014, background): “For example, in [30] nanoparticles are used to target particular tissue types.”
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. (2011, background): “The isoelectric point of SPIONs is around pH 7 [218,219], which is same as that for biological fluids; hence, the colloidal stability of SPIONs in such surrounding environments is recognized as a major shortcoming [220,221].”
Molecular Communication and Networking: Opportunities and Challenges (2012, background): “Information molecules can also be synthesized for specific purposes as demonstrated in drug delivery by, for example, using nanoparticles to target particular tissue types [42].”
Biomedical applications of functionalised carbon nanotubes. (2005, background): “Among the currently available delivery systems, which include liposomes, emulsions, polymers and microparticles ( Lavan et al., 2003; Martin and Kohli, 2003; Allen and Cullis, 2004), carbon nanotubes (CNTs) have recently gained popularity as potential drug carriers, therapeutic agents and diagnosti”